Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 Ackermans & van Haaren NV ACKB Apr 25, 2025 211.00 +0.67   
 Aedifica SA AED Apr 25, 2025 67.75 +0.52   
 Ageas AGS Apr 25, 2025 53.70 -0.09   
 Agfa-Gevaert NV AGFB Apr 25, 2025 0.90 -1.86   
 AHOLD DEL AD Apr 25, 2025 35.70 -0.56   
 APERAM APAM Apr 25, 2025 27.32 +1.34   
 Argen X SE ARGX Apr 25, 2025 535.80 +0.79   
 Ascencio Sca ASCE Apr 25, 2025 46.60 +0.43   
 Atenor ATEB Apr 25, 2025 2.90 -1.69   
 AVANTIUM AVTX Apr 25, 2025 0.77 +2.67   
 Azelis Group NV AZE Apr 25, 2025 13.61 +3.42   
 Banco Bilbao Vizcaya Argentaria SA BBV Apr 25, 2025 7.80 0.00   
 Banco Santander SA SANTA Apr 25, 2025 3.58 0.00   
 Banimmo SA BANI Apr 25, 2025 2.92 +1.37   
 Banque Nationale de Belgique BNB Apr 25, 2025 345.00 +5.18   
 Barco NV BAR Apr 25, 2025 11.95 -0.17   
 Basilix BAS Apr 25, 2025 27.80 0.00   
 Beaulieu Av Certificates BEAB Apr 25, 2025 1.19 0.00   
 Befimmo SA BEFB Apr 25, 2025 46.10 0.00   
 Bel20 BEL20 Apr 25, 2025 4 306.05 +0.37   
 Belreca - Belgian Resources and Capital Company BELR Apr 25, 2025 7.50 0.00   
 Beluga NV BELU Apr 25, 2025 0.32 0.00   
 Belysse Group N.V. BELYS Apr 25, 2025 0.79 +1.95   
 Biocartis Group NV BCART Apr 25, 2025 0.29 0.00   
 Biosenic BIOS Apr 25, 2025 0.00 0.00   
 Biotalys BTLS Apr 25, 2025 3.17 -0.31   
 Boeing BOEI Apr 25, 2025 224.00 0.00   
 Bone Therapeutics S.A. BOTHE Apr 25, 2025 0.29 0.00   
 Bpost S.A. / N.V BPOST Apr 25, 2025 1.42 -3.13   
 Brederode S.A. BREB Apr 25, 2025 110.90 +0.42   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.